PT1259606E - Composições utilizáveis para regular a actividade da parkina - Google Patents

Composições utilizáveis para regular a actividade da parkina Download PDF

Info

Publication number
PT1259606E
PT1259606E PT01907820T PT01907820T PT1259606E PT 1259606 E PT1259606 E PT 1259606E PT 01907820 T PT01907820 T PT 01907820T PT 01907820 T PT01907820 T PT 01907820T PT 1259606 E PT1259606 E PT 1259606E
Authority
PT
Portugal
Prior art keywords
leu
thr
gin
lys
ser
Prior art date
Application number
PT01907820T
Other languages
English (en)
Portuguese (pt)
Inventor
Alain Fournier
Alexis Brice
Laurent Pradier
Hana Koutnikova
Catherine Prades
Isabelle Arnould-Reguigne
Marie-Francoise Rosier-Montus
Olga Corti
Original Assignee
Aventis Pharma Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Inst Nat Sante Rech Med filed Critical Aventis Pharma Sa
Publication of PT1259606E publication Critical patent/PT1259606E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT01907820T 2000-02-17 2001-02-15 Composições utilizáveis para regular a actividade da parkina PT1259606E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0001980A FR2805266B1 (fr) 2000-02-17 2000-02-17 Compositions utilisables pour reguler l'activite de la parkine
US19848900P 2000-04-18 2000-04-18

Publications (1)

Publication Number Publication Date
PT1259606E true PT1259606E (pt) 2010-08-02

Family

ID=8847103

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01907820T PT1259606E (pt) 2000-02-17 2001-02-15 Composições utilizáveis para regular a actividade da parkina

Country Status (6)

Country Link
JP (1) JP4861590B2 (https=)
DK (1) DK1259606T3 (https=)
ES (1) ES2345318T3 (https=)
FR (1) FR2805266B1 (https=)
PT (1) PT1259606E (https=)
ZA (1) ZA200206550B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116254286B (zh) * 2022-12-23 2024-07-12 厦门大学 氰胺诱导的酿酒酵母工程菌及其构建方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2449501A (en) * 1999-12-21 2001-07-03 Incyte Genomics, Inc. Vesicle trafficking proteins

Also Published As

Publication number Publication date
ES2345318T3 (es) 2010-09-21
ZA200206550B (en) 2003-12-19
JP4861590B2 (ja) 2012-01-25
FR2805266B1 (fr) 2004-12-03
FR2805266A1 (fr) 2001-08-24
DK1259606T3 (da) 2010-08-23
JP2003523193A (ja) 2003-08-05

Similar Documents

Publication Publication Date Title
DE60132075T2 (de) Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
Komuro et al. Gtx: a novel murine homeobox‐containing gene, expressed specifically in glial cells of the brain and germ cells of testis, has a transcriptional repressor activity in vitro for a serum‐inducible promoter.
US20160353720A1 (en) Sperm-specific cation channel, catsper4, and uses therefor
US8859197B2 (en) Sperm-specific cation channel, CATSPER3, and uses therefor
IL193310A (en) An antibody against a polypeptide which reacts with Parkin and medicinal preparations containing it
US20170164591A1 (en) Sperm-Specific Cation Channel, Catsper2, and Uses Therefor
US7339029B2 (en) Sperm-specific cation channel, CatSper2, and uses therefor
JP4011629B2 (ja) 新規セマフォリン遺伝子(i)
EP1354946B1 (en) Bhlh-pas proteins, genes thereof and utilization of the same
PT1259606E (pt) Composições utilizáveis para regular a actividade da parkina
DE60113535T2 (de) Kompositionen und verwendungen von cgi-69
WO1997038004A1 (en) Gene family associated with neurosensory defects
AU2006235783B8 (en) Compositions useful for regulating parkin gene activity
DE60024862T2 (de) "insulinabhängiges sequenz dna bindendes protein-1" (irsdbp-1), dafür kodierendes gen und ihre verwendungen
US6268130B1 (en) RP compositions and diagnostic uses therefor
CA2437960A1 (en) Als2 gene and amyotrophic lateral sclerosis type 2
TWI250209B (en) A novel G protein-coupled receptor, GAVE8
US20040137450A1 (en) Als2 gene and amyotrophic lateral sclerosis type 2